Nigerian equities rallied during Friday’s trading session, driven by investor optimism following FTSE Russell’s confirmation of thirty-one Nigerian stocks for its Frontier Index Series. This follows Nigeria’s official reclassification to Frontier Market status, effective September 21, 2026. Market analysts expect the transition to improve global visibility, liquidity, and foreign portfolio inflows, particularly for large-cap stocks that meet the index criteria. The NGX All Share Index rose to 247,016 points, with banking sector gains leading the market activity.

The Nigerian stock market extended its recent rally on Monday, August 31, 2026, adding N1.91 trillion in market capitalization. The NGX All-Share Index rose 1.20% to close at 244,199.39 points, lifting the year-to-date return to 56.93%. The positive momentum follows FTSE Russell’s recent reclassification of Nigeria as a Frontier Market. Trading activity was robust, with 606.19 million shares exchanged for N38.70 billion. Banking stocks led the gains, with the Banking Index surging 3.11% as investors reacted to improved market sentiment. 43 stocks advanced while 16 declined.

May & Baker Nigeria Plc led the pharmaceutical sector in profitability for the first half of 2026, achieving a net profit margin of 16.59 percent. While the combined profit margin for five major listed pharma firms rose to 10.24 percent, May & Baker’s performance was distinct because it stemmed from improved cost efficiency rather than top-line revenue growth. Fidson Healthcare followed with a 10.37 percent margin, while MeCure Industries and Neimeth International Pharmaceuticals recorded 7.76 percent and 5.65 percent respectively. Morison Industries trailed the group, posting a net loss for the period.